Open Access

Probucol protects circulating endothelial progenitor cells from ambient PM2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo

  • Authors:
    • Yong Chen
    • Ke Hu
    • Haoran Bu
    • Zhihua Si
    • Haihui Sun
    • Liming Chen
    • Hang Liu
    • Hao Xie
    • Peng Zhao
    • Le Yang
    • Qinghua Sun
    • Zhenguo Liu
    • Lianqun Cui
    • Yuqi Cui
  • View Affiliations

  • Published online on: September 24, 2018     https://doi.org/10.3892/etm.2018.6791
  • Pages: 4322-4328
  • Copyright: © Chen et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Bone marrow‑derived circulating endothelial progenitor cells (EPCs) contribute to angiogenesis and vascular repair. The number and function of EPCs are significantly decreased following exposure to ambient fine particulate matter of ≤2.5 µm in diameter (PM2.5) through reactive oxygen species (ROS) generation and inflammatory cytokine secretion. The anti‑oxidant drug probucol reduces ROS and inflammatory cytokine production. The present study was designed to determine the protective effects of probucol on EPCs from PM2.5‑associated impairment in vivo and to explore the potential underlying mechanisms. Male C57BL/6 mice were exposed to ambient air containing PM2.5 for one month with or without probucol treatment. Mice that breathed filtered air were used as a control group. Serum and blood cells were collected for analysis. The results indicated that PM2.5 exposure induced increases in blood intracellular ROS, serum inflammatory cytokine levels and the blood cell apoptotic rate, while it decreased the number and proliferation rate of circulating EPCs in the mice with PM2.5 exposure. These effects were significantly reduced/abrogated by probucol treatment. The present in vivo study suggested that probucol protects EPCs from damage through PM2.5 exposure by inhibiting ROS generation and inflammatory cytokine production.
View Figures
View References

Related Articles

Journal Cover

December-2018
Volume 16 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Chen Y, Hu K, Bu H, Si Z, Sun H, Chen L, Liu H, Xie H, Zhao P, Yang L, Yang L, et al: Probucol protects circulating endothelial progenitor cells from ambient PM2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo. Exp Ther Med 16: 4322-4328, 2018.
APA
Chen, Y., Hu, K., Bu, H., Si, Z., Sun, H., Chen, L. ... Cui, Y. (2018). Probucol protects circulating endothelial progenitor cells from ambient PM2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo. Experimental and Therapeutic Medicine, 16, 4322-4328. https://doi.org/10.3892/etm.2018.6791
MLA
Chen, Y., Hu, K., Bu, H., Si, Z., Sun, H., Chen, L., Liu, H., Xie, H., Zhao, P., Yang, L., Sun, Q., Liu, Z., Cui, L., Cui, Y."Probucol protects circulating endothelial progenitor cells from ambient PM2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo". Experimental and Therapeutic Medicine 16.6 (2018): 4322-4328.
Chicago
Chen, Y., Hu, K., Bu, H., Si, Z., Sun, H., Chen, L., Liu, H., Xie, H., Zhao, P., Yang, L., Sun, Q., Liu, Z., Cui, L., Cui, Y."Probucol protects circulating endothelial progenitor cells from ambient PM2.5 damage via inhibition of reactive oxygen species and inflammatory cytokine production in vivo". Experimental and Therapeutic Medicine 16, no. 6 (2018): 4322-4328. https://doi.org/10.3892/etm.2018.6791